Why This Little Known Biotech Is Pharma's New Poster Child for Price Gouging Post author:Sam Post published:December 19, 2017 Post category:BioPharma Another lawmaker is taking on a pharmaceutical company for drug pricing. Source: BioSpace You Might Also Like Bay Area Biotech Forges Multi-Year Research Deal with Genentech December 18, 2017 Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018 Active Implants Appoints And To Board July 11, 2017
Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018